Skip to main content
main-content

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Journal of Neuroinflammation 1/2017

Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes

Zeitschrift:
Journal of Neuroinflammation > Ausgabe 1/2017
Autoren:
Vincent R. Parillaud, Guillaume Lornet, Yann Monnet, Anne-Laure Privat, Andrei T. Haddad, Vanessa Brochard, Amaury Bekaert, Camille Baudesson de Chanville, Etienne C. Hirsch, Christophe Combadière, Stéphane Hunot, Christian S. Lobsiger
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12974-017-0830-9) contains supplementary material, which is available to authorized users.

Abstract

Background

Evidence from mice suggests that brain infiltrating immune cells contribute to neurodegeneration, and we previously identified a deleterious lymphocyte infiltration in Parkinson’s disease mice. However, this remains controversial for monocytes, due to artifact-prone techniques used to distinguish them from microglia. Our aim was to reassess this open question, by taking advantage of the recent recognition that chemokine receptors CCR2 and CX3CR1 can differentiate between inflammatory monocytes and microglia, enabling to test whether CCR2+ monocytes infiltrate the brain during dopaminergic (DA) neurodegeneration and whether they contribute to neuronal death. This revealed unexpected insights into possible regulation of monocyte-attracting CCL2 induction.

Methods

We used acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice and assessed monocyte infiltration by combining laser microdissection-guided chemokine RNA profiling of the substantia nigra (SN) with immunohistochemistry and CCR2-GFP reporter mice. To determine contribution to neuronal loss, we used CCR2-deletion and CCL2-overexpression, to reduce and increase CCR2+ monocyte infiltration, and CX3CR1-deletion to assess a potential implication in CCL2 regulation.

Results

Nigral chemokine profiling revealed early CCL2/7/12-CCR2 axis induction, suggesting monocyte infiltration in MPTP mice. CCL2 protein showed early peak induction in nigral astrocytes, while CCR2-GFP mice revealed early but limited nigral monocyte infiltration. However, blocking infiltration by CCR2 deletion did not influence DA neuronal loss. In contrast, transgenic astrocytic CCL2 over-induction increased CCR2+ monocyte infiltration and DA neuronal loss in MPTP mice. Surprisingly, CCL2 over-induction was also detected in MPTP intoxicated CX3CR1-deleted mice, which are known to present increased DA neuronal loss. Importantly, CX3CR1/CCL2 double-deletion suggested that increased neurotoxicity was driven by astrocytic CCL2 over-induction.

Conclusions

We show that CCR2+ monocytes infiltrate the affected CNS, but at the level observed in acute MPTP mice, this does not contribute to DA neuronal loss. In contrast, the underlying astrocytic CCL2 induction seemed to be tightly controled, as already moderate CCL2 over-induction led to increased neurotoxicity in MPTP mice, likely due to the increased CCR2+ monocyte infiltration. Importantly, we found evidence suggesting that during DA neurodegeneration, this control was mediated by microglial CX3CR1 signaling, which protects against such neurotoxic CCL2 over-induction by astrocytes, thus hinting at an endogenous mechanism to limit neurotoxic effects of the CCL2-CCR2 axis.
Zusatzmaterial
Additional file 1: Figure S1. Global neuroinflammation and neurodegeneration in the substantia nigra of acute MPTP model mice. (A-C) Immunohistochemical stainings (anti-TH; brown) of DA neuronal degeneration at 2d (B) and loss at 7d (C) after acute MPTP intoxication in wild-type mice (C57BL/6J). Quantification shows the expected stable loss of around 30% of DA neurons (11,680 +/− 240, saline, n = 3; 8410 +/− 440, MPTP, n = 10) (28% loss; P < 0.05, Holm-Sidak method). Immunofluorescence stainings of (D-F) microglial activation (Iba1, red) in the SNpc during MPTP-mediated DA neurodegeneration (TH, green), showing clear signs of microglial reactivity already at 2 days after MPTP intoxication (before the peak of DA neuronal loss, at 4 days) and which is further increased until 7 days (after the peak of DA neuronal loss, when neuronal death has reached a stable level). (G-I). Astroglial activation, as measured by GFAP activation (GFAP, red), is delayed compared to microglial activation, only getting strongly induced between 2–7 days after MPTP intoxication. (Scale bar: F, 200 μm). (PDF 3173 kb)
12974_2017_830_MOESM1_ESM.pdf
Additional file 2: Table S1. RNA profiling of chemokines in the laser-microdissected substantia nigra of the MPTP mouse model. Shown are results from the RT-qPCR profiling of 96 genes using TaqMan 384-well microfluidic cards, to assess all 61 chemokine family members (37 ligands, 24 receptors) as well as 32 other selected neuroinflammation-linked genes, normalized to Hprt1. RNA profiling was done in laser-microdissected SNpc at 2, 4, and 7 days after acute MPTP intoxication in adult 12 weeks old C57BL/6J males and compared to saline-injected controls (n = 9 mice per condition; as biological replicates). qPCR results are shown as normalized and averaged fold-changes (FC) to saline controls. In addition, the raw averaged Ct values of both the control and the 2 days (MPTP) samples are shown. Ct values of >30 are called absent (Abs). Only FC values that are statistically significant (P < 0.05; qBasePlus, Biogazelle) are indicated. Of note, the large FC values can be explained by both the enrichment provided by the LMD and the often very low expression in baseline control conditions. (nc, expressed but no significant change and N.D., non-determined) (* asterisks mark unclear corresponding receptors; Griffith et al. 2014). (PDF 163 kb)
12974_2017_830_MOESM2_ESM.pdf
Additional file 3: Figure S2. RNA profiling of the full chemokine family in the laser-microdissected substantia nigra of MPTP mice. (A) Representative example of a RNA integrity analysis of RNA isolated from laser-microdissected SNpc regions (50 per mouse, resulting in 50 ng of total RNA) of fresh frozen Nissl-stained sections and showing sufficient quality RNA for qPCR analysis (RIN >7; BioAnalyzer, PicoAssay II). (B) Results show all the chemokines (ligands only) found to be regulated (TaqMan RT-qPCR arrays; at 2, 4, and/or 7 days after acute MPTP intoxication) in the SNpc during DA neurodegeneration (27 of the 37 chemokines tested). Four regulation profiles (Additional file 2: Table S1B) can be distinguished: (“ profile A”) : 10 chemokines showing strong early peak induction at 2 days, then less strong induction at 4 and 7 days ( Ccl2/3/4/7/8/12/22, Cxcl2/10/11); (“ profile B”) : 10 chemokines showing early but persistent induction (at 2/4 and 7 days) ( Ccl5/9/11/19, Cxcl1/5-6/4/9/14/16); (“ profile C): 2 chemokines showing increased upregulation at the late timepoint ( Ccl6, xCl1), and (“ profile D”): 4 chemokines showing persistent ( Ccl20/28) or late downregulation ( Ccl17/Cxcl13). In addition, one chemokine (CCL24) showed a mixed regulation (early down, then upregulated) (Additional file 2: Table S1B). (PDF 505 kb)
Additional file 4: Figure S3. CCL2 deleted mice confirm high specificity of the used anti-CCL2 antibody. (A-D) Immunofluorescence stainings of LPS-injected midbrain region (48 h after injection, known to produce a strong neuroinflammatory reaction which induces CCL2) to assess anti-CCL2 antibody specificity. (A, C) Results show strong CCL2 positive signal (red), partially colocalizing with astrocytes (GFAP, green; inset in C) in wild-type mice (CCL2+/+), while this CCL2 signal is completely absent in CCL2 deleted mice (CCL2−/−) (B, D), demonstrating specificity of the anti-CCL2 antibody used. (Scale bars; C, 200 μm; C’, 50 μm). (PDF 3822 kb)
12974_2017_830_MOESM4_ESM.pdf
Additional file 5: Figure S4. Induction of the additional two CCR2 ligands, astrocytic CCL7 and microglial CCL12, within the affected substantia nigra of MPTP mice. (A-F) Immunofluorescence stainings to show that CCL7 (a ligand for CCR2, like CCL2) (red) is not induced under control saline conditions in the SNpc (dotted white line) (A, D) but gets induced (red, arrows) 24 h after MPTP intoxication (peak induction) in selected cells, that are not microglia (Iba1, green; arrowheads; with enlargement in C’) (B, C), but astrocytes (GFAP, green, arrows) (E-F) (with a confocal orthogonal view in F’). (G-L) Immuno stainings to show that CCL12 (a ligand for CCR2, like CCL2) (red) is not induced under control saline conditions in the SNpc (dotted white line) (G) but gets induced (red, arrows) 24 h after MPTP intoxication (peak induction) in microglia (H-I) (Iba1, green; with enlargements in I’). This is also shown using confocal analysis (J-L). (Scale bars; F, I, 200 μm; C’, I’, 40 μm; F’, L, 20 μm). (PDF 4791 kb)
12974_2017_830_MOESM5_ESM.pdf
Additional file 6: Figure S5. Immunostaining characteristics of secreted (CCL2/12) and membrane-bound (CXCL16) chemokines identified in the affected substantia nigra of MPTP mice. (A-I) Immunofluorescence stainings to provide support for the specificity of the identified vesicular staining-patterns detected for the secreted chemokines CCL2 (red, arrow) in astrocytes (A-C) (GFAP, green; with confocal analysis in C’) and CCL12 (red, arrows) (D-F) in microglia (Iba1, green; TH, blue; with confocal analysis in F’), by comparing to the membranous staining-pattern detected for the membrane-bound chemokine CXCL16 (G-I) in microglia (Iba1, green; TH, blue; with confocal analysis in I’). (Scale bars; C, F, I, 20 μm). (PDF 1781 kb)
12974_2017_830_MOESM6_ESM.pdf
Additional file 7: Figure S6. CCR2+ monocytes infiltrating the affected substantia nigra in MPTP mice are present both perivascular and parenchymal. (A-F) Immunofluorescence stainings within the SNpc (anti-TH, blue) of CCR2-GFP mice, 24 h after MPTP intoxication to show both (A-C) CCR2-GFP+ cells (anti-GFP, green, arrows) with a localization at blood vessel endothelial cells (lectin, red, arrowheads), as well as (D-F) with a localization within the parenchyma, consistent with recently infiltrated CCR2-GFP+ monocytes. Of note, lectin can also mark microglia, but at the concentration used, mostly vessels. (G-H) Confirmatory stainings to show a specific vessel marker (anti-Collagen-IV; red, arrowheads), with parenchymal localization of CCR2-GFP+ monocytes in the SNpc (GFP; green, arrows). (Scale bars: F, H, 50 μm). (PDF 3580 kb)
12974_2017_830_MOESM7_ESM.pdf
Additional file 9: Figure S8. Quantitative analysis of presence of CCR2+ monocytes and induction of CCL2 within the striatum of MPTP mice. (A) Full timecourse analysis of the presence of CCR2-GFP+ cells (inset left; GFP, brown) within the striatum of MPTP treated CCR2-GFP mice (from 12 h to 7 days after MPTP intoxication). CCR2-GFP+ cells (inset right) were double-positive for GFP (green) and cd11b (red), identifying them as monocytes. While there was a trend for an increase at 36 h after MPTP intoxication, this did not reach statistical significance (n.s.; P > 0.05; Kruskal-Wallis test). Of note, in contrast to the striatum, in the substantia nigra, an increased CCR2+ monocyte infiltration was measured at 36 h after intoxication (see, Fig.  4d). Counts represent average CCR2-GFP + cells within a striatal section (means +/− SEM; 5–10 section counted; n = 4 mice per condition). (Scale bar; A, 10 μm). ( B) Analysis of striatal CCR2 + monocyte infiltration in MPTP mice with transgenic over-induction of astrocytic CCL2. A significant increase in striatal CCR2 + monocyte infiltration was measured (at 24 h after MPTP intoxication) in CCR2-GFP/GFAP-CCL2 mice as compared to CCR2-GFP littermates ( n = 4 mice per condition; *P < 0.05; t test). Of note, this was comparable to the significant increased CCR2 + monocyte infiltration that was detectable (at 24 h after intoxication) in the substantia nigra of CCR2-GFP/GFAP-CCL2 mice (see, Fig.  6c). ( C) Analysis of striatal astrocytic CCL2 induction in MPTP mice with deletion for CX3CR1. A significant increased numbers of astrocytes inducing CCL2 was measured (at 24 h after intoxication) in CX3CR1 −/− mice as compared to wild-type CX3CR1 +/+ littermates ( n = 4 mice per condition; *P < 0.05; t test). Of note, this was comparable to the significant increased numbers of astrocytes inducing CCL2 that was detectable in the substantia nigra of CX3CR1-deleted mice (see, Fig.  7e). (PDF 682 kb)
Additional file 10: Figure S9. Confirmation of CCL2 overexpression in GFAP-CCL2 mice. (A-C) Immunofluorescence stainings showing that baseline overexpression of CCL2 (red) in control (saline-injected) GFAP-CCL2/CCR2-GFP double-transgenic mice is mostly localized around, but less within the SNpc (A), which is marked with TH (blue). Only very rare CCR2-GFP+ cells (green) are detected under baseline conditions in or around the SNpc (B). (D-I) Strong CCL2 induction (red) is detected in the SNpc (marked with TH, blue) of MPTP treated GFAP-CCL2/CCR2-GFP double transgenic mice (D and inset, G), leading to increased presence of CCR2-GFP+ cells (green) in the affected SNpc (E-F and insets, H-I) (measured at 24 h after intoxication). (Scale bars; B, 200 μm; I, 20 μm). (PDF 1619 kb)
12974_2017_830_MOESM10_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

Journal of Neuroinflammation 1/2017 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Meistgelesene Bücher in der Neurologie & Psychiatrie

  • 2016 | Buch

    Neurologie

    Das Lehrbuch vermittelt Ihnen das gesamte Neurologie-Prüfungswissen für Ihr Medizinstudium und bereitet auch junge Assistenzärzte durch detailliertes Fachwissen optimal auf die Praxis vor. Die komplett überarbeitete Auflage enthält sechs neue, interdisziplinäre Kapitel.

    Herausgeber:
    Werner Hacke
  • 2016 | Buch

    Komplikationen in der Neurologie

    Das Buch schildert Ereignisse im Rahmen der Neuromedizin, die während der Diagnostik und Therapie neurologischer Erkrankungen und Symptome auftreten können. Die Fallbeispiele sensibilisieren Sie für mögliche Risikofaktoren, um das Auftreten solcher Komplikationen zu vermeiden.

    Herausgeber:
    Frank Block
  • 2017 | Buch

    Facharztwissen Psychiatrie, Psychosomatik und Psychotherapie

    Leitsymptome, Untersuchungsmethoden, Krankheitsbilder, Notfälle & Co. – mit der Neuauflage des "Facharztwissens" sind Sie auf die Facharztprüfung in Psychiatrie und Psychotherapie optimal vorbereitet. In dieser 2. Auflage sind die Kapitel zu psychosomatischen Störungen deutlich ausgebaut.

    Herausgeber:
    Prof. Dr. Dr. Frank Schneider
  • 2019 | Buch

    Kompendium der Psychotherapie

    Für Ärzte und Psychologen

    Dieses Werk wendet sich an Ärzte und Psychologen, die an psychiatrischen und psychosomatischen Kliniken oder an Psychotherapeutischen Ausbildungsinstituten arbeiten und in den vorhandenen Lehrbüchern der Psychotherapie den Brückenschlag zur …

    Herausgeber:
    Tilo Kircher